AccelPath, Inc. (ACLP) (“AccelPath” or the “Company”) announced today that Professor Leslie F. Greengard, M.D., Ph.D., has been appointed to the Company’s Medical Advisory Board.
Professor Greengard is a Professor of Mathematics and Computer Science at the Courant Institute of Mathematical Sciences at New York University. He received his B.A. degree in Mathematics from Wesleyan University in 1979, his M.D., and Ph.D. degree in Computer Science, from Yale University in 1987. He has been at the Courant Institute since 1989, and served as the director of the Institute from 2006-2011.
Research in Professor Greengard's group is largely focused on developing fast and adaptive algorithms for computational problems in biology, chemistry, materials science, medicine, and physics. He is best-known for having developed the fast multipole method (FMM) during the 1980s with Professor V. Rokhlin, which is now widely used in electromagnetics, astrophysics, molecular simulations, and fluid dynamics. He currently works on protein design, the analysis of "metamaterials," electromagnetic theory, diffusion in complex geometry, and magnetic resonance imaging.
Professor Greengard has been an NSF Presidential Young Investigator and a Packard Foundation Fellow. He received the Leroy P. Steele Prize from the American Mathematical Society in 2001 and the Sokol Faculty Award in the Sciences from NYU in 2004. In 2006, he was elected to both the National Academy of Sciences and the National Academy of Engineering.
“After numerous discussions with AccelPath’s management and board members, I am pleased to join the Company’s Medical Advisory Board,” stated Professor Greengard. “The Company is on an exciting road of implementing digital telepathology networks in the US and abroad. The Company also has powerful 3D imaging technology with multiple applications in medicine. I look forward to contributing to the Company’s ongoing successes.”
“We are very pleased to have formalized a collaborative relationship with Professor Greengard,” stated Shekhar Wadekar, AccelPath’s Chairman and Chief Executive Officer. “Professor Greengard’s expertise in developing fast and adaptive algorithms is a key component to enhancing efficiencies in digital whole slide imaging and 3D imaging. Professor Greengard will help enhance the Company’s proprietary 3D digital imaging technology, which has several medical applications. This 3D imaging technology was acquired as part of the Company’s acquisition of Technest Holdings in 2011. We will continue to exploit the value of this technology, as it relates to non-core applications, while pursuing our core business of digital telepathology and the applications for this technology in medicine.”